| RS2147492697 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147495562 |
CASK
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS2147495667 |
CASK
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2147496735 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147497386 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Kennedy disease |
| RS2147497751 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147497993 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147503631 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2147503858 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147504920 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2147506322 |
MEGF8
|
Health Risk |
Pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS2147508108 |
SMS
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Snyder type, Syndromic X-linked intellectual disability Snyder type |
| RS2147509524 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509613 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509622 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509660 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509712 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509771 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509775 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509825 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509853 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509886 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147509932 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147511678 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, EDA-related disorder |
| RS2147511696 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147511758 |
EDA
|
Health Risk |
Likely pathogenic |
— |
| RS2147513193 |
SMS
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Snyder type, Syndromic X-linked intellectual disability Snyder type |
| RS2147516240 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147516257 |
EDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypohidrotic X-linked ectodermal dysplasia, Asphyxiating thoracic dystrophy 3 |
| RS2147516267 |
EDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS2147516275 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Thyroid cancer |
| RS2147516523 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147516557 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147516572 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147517480 |
SMS
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Syndromic X-linked intellectual disability Snyder type |
| RS2147517821 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2147517939 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2147518591 |
MSN
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to moesin deficiency, Combined immunodeficiency due to moesin deficiency |
| RS2147518914 |
EDA
|
Health Risk |
Pathogenic |
— |
| RS2147518971 |
EDA
|
Health Risk |
Likely pathogenic |
— |
| RS2147518992 |
MSN
|
Health Risk |
Pathogenic |
— |
| RS2147519167 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147519270 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS2147519353 |
SH2D1A
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, Autoinflammatory syndrome |
| RS2147519384 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147519411 |
EDA
|
Health Risk |
Likely pathogenic |
— |
| RS2147519482 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS2147523033 |
OTUD5
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-neurodevelopmental syndrome, X-linked |
| RS2147523877 |
OPHN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS2147524252 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147524430 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147524833 |
AR
|
Health Risk |
Likely pathogenic |
Partial androgen insensitivity syndrome, Partial androgen insensitivity syndrome |
| RS2147524850 |
AR
|
Health Risk |
Pathogenic |
Male infertility, Male infertility |
| RS2147524930 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147524944 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147524993 |
AR
|
Health Risk |
Likely pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147525149 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Nonpapillary renal cell carcinoma |
| RS2147525286 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147525351 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147525357 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147530549 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147530668 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147530773 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147530793 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147530802 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147530836 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147530850 |
ACE
|
Health Risk |
Pathogenic |
— |
| RS2147530857 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147530924 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147530929 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147531195 |
AR
|
Health Risk |
Likely pathogenic |
Partial androgen insensitivity syndrome, Partial androgen insensitivity syndrome |
| RS2147531326 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2147531379 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2147531380 |
SH2D1A
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS2147532974 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147533042 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147533057 |
PLS3
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2147533064 |
PLS3
|
Health Risk |
Likely pathogenic |
Bone mineral density quantitative trait locus 18, Nonpapillary renal cell carcinoma |
| RS2147533148 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147533347 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147533439 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147533687 |
ACE
|
Health Risk |
Pathogenic |
— |
| RS2147534019 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2147534047 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2147534056 |
SH2D1A
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2147534220 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2147534335 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147535484 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147535489 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2147535633 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2147535891 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147536129 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147537315 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147537479 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2147537756 |
AR
|
Health Risk |
Likely pathogenic |
AR-related disorder, Androgen resistance syndrome |
| RS2147537798 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147537806 |
AR
|
Health Risk |
Pathogenic |
Male infertility, Non-obstructive azoospermia |
| RS2147537831 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147537840 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147537854 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |